echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The latest progress of epidemiological investigation of patients with multiple sclerosis in Guangzhou

    The latest progress of epidemiological investigation of patients with multiple sclerosis in Guangzhou

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiple sclerosis (MS) is a lifelong, highly disabling, relapsing autoimmune disease that is rare in China, and accurately estimating the prevalence of MS is critical



    Overview of the study


    The research team conducted a prospective, population-based study


    Figure 1 Distribution map of 17 top three hospitals in Guangzhou city where CASE searches were conducted for MS patients


    Research results


    As of December 31, 2021, based on McDonald's (2017) diagnostic criteria and Guangzhou Medical Insurance's population inclusion criteria, the team identified a total of 143 MS patients (including 43 males and 100 females).


    The study population ranged from 7 to 73 years, with a median age of 30 years and a female-to-male ratio of 2.


    Figure 2 Age-corrected prevalence of patients with multiple sclerosis in Guangzhou


    Conclusions of the study


    The study was the first to use the latest McDonald (2017) diagnostic criteria to estimate


    References: Liu Z, Nie Z, Lu Y, Sun J, Zhou L, Long Y, Wang H, Feng H, li Y, Wang Z, Zhao Y, Du B, Guo A, Qiu W.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.